Abstract
Objective
To investigate adherence to prescription in a female population aged 35–65 years.
Design
Postal questionnaire study of 2991 randomly sampled 35- to 64-year-old women in seven provinces of central Sweden.
Methods
The study was performed in 1995 as a cross-sectional postal questionnaire study in seven counties in central Sweden. The questionnaire was sent to a random sample of 4200 women between the ages of 35 and 64, of whom 2991 (71.2%) responded. The questionnaire asked about drugs prescribed during the past year and about factors potentially affecting adherence.
Results
The same women had different degrees of adherence to different medications. A large number of factors were associated with adherence. Multivariate analysis revealed that age, scheduled check-up, perceived importance of medication, concerns about medication safety and taking medication for a respiratory or a cardiovascular disease were significantly related to adherence. Adherence ranged from 15–98% depending on these factors, and was the lowest among young women who regarded their medication as unimportant and who had no scheduled check-up; the highest reported adherence was found among elderly women who regarded their medication as important and who had a scheduled check-up.
Conclusion
Factors that were associated with the perceived importance of medication had a positive effect on adherence, while concerns about medication safety had a negative effect.
Similar content being viewed by others
References
Andrade SE, Walker AM, Gottlieb LK, Hollenberg NK, Testa MA, Saperia GM, Platt R (1995) Discontinuation of antihyperlipidemic drugs -Do rates reported in clinical trial reflect rates in primary care settings? N Engl J Med 332:1125–1231
Aspegren K (1999) Teaching and learning communication skills in medicine-a review with quality grading of articles. Med Teach 21:563–570
Bardel A, Wallander MA, Svärdsudd K (2000) Reported current use of prescription drugs and some of its determinants among 35 to 65-year-old women in mid-Sweden: A population-based study. J Clin Epidemiol 53:637–643
Bloom BS (1998) Continuation of initial antihypertensive medication after 1 year of therapy. Clin Ther 20:671–681
Boethius G (1977) The recording of drug prescriptions in the county of Jämtland. Acta Med Scand 202:241–251
Carter WB, Inui TS, Kukull W, Haig VH (1982) Outcome-based doctor-patient interaction analysis: II. Identifying effective provider and patient behaviour. Med Care 20:550–566
Cramer JA, Scheyer RD, Mattson RH (1990) Compliance declines between clinic visits. Arch Intern Med 150:1509–1510
Eagle K, Kline-Rogers E, Goodman SG, Gurfinkel EP, Avezum A, Flather MD, Granger CB, Erickson S, White K, Steg PG (2004) Adherence to evidence-based therapies after discharge for acute coronary syndromes. An ongoing, prospective, observational study. Am J Med 117:73–81
Farmer KC (1999) Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther 21:1074–1090
Garber MC, Nau DP, Erickson SR, Aikens JE, Lawrence JB (2004) The concordance of self-report with other measure of medication adherence a summary of the literature. Med Care 42:649–652
Grant RW, Devita NG, Singer DE, Meigs JB (2003) Polypharmacy and medication adherence in patients with type 2 diabetes. Diabetes Care 26:51408–1412
Harlow SD, Linet MS (1989) Agreement between questionnaire data and medical records. The evidence for accuracy of recall. Am J Epidemiol 129:223–248
Haynes RB, Taylor DW, Sachett D, Gibson ES, Bernholz CD, Murkherjee J (1980) Can simple clinical measurements detect patient noncompliance? Hypertension 2:757–764
Haynes RB, McKibbon KA, Kanani R (1996) Systematic review off randomised trails of interventions to assist patients to follow prescriptions for medications. Lancet 348:383–386
Horne R, Weinman J (1999) Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 47:555–567
Insull W (1997) The problem of compliance to cholesterol altering therapy. J Int Med 241:317–325
Jackevicius CA, Mamdani M, Tu JV (2002) Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA 288:462–467
JMP User’s guide (2000) SAS Institute Cary, N.C.
Kiortsis DN, Giral P, Bruckert E, Turpin G (2000) Factors associated with low compliance with lipid-lowering drugs in hyperlipidemic patients. J Clin Pharm Ther 25:445–451
Laidlaw TS, MacLeod H, Kaufman DM, Langille DB, Sargeant J (2002) Implementing a communication skills program in medical school: needs assessment and programme change. Med Educ 36:115–124
Lindgren R, Berg G, Hammar M, Zuccon E (1993) Hormonal replacement therapy and sexuality in a population of Swedish postmenopausal women. Acta Obst Gynecol Scand 72:292–297
Loiseau P, Marchal C (1988) Determinants of compliance in epileptic patients. Epilepsy Res Suppl 1:135–140
Matsui D, Hermann C, Klein J, Berkovitch M, Olivieri N, Koren G (1994) Critical comparison of novel and existing methods of compliance assessment during a clinical trial of an oral iron chelator. J Clin Pharmacol 34:944–949
Popa-Lisseanu MGG, Greisinger A, Richardson M, O’Malley KJ, Janssen NM, Marcus DM, Tagore J, Suarez-Almazor M (2005) Determinants of treatment. Adherence in ethnically diverse, economically disadvantaged patients with rheumatic disease. J Rheumatol 32:913–928
Richter A, Anton SF, Koch P, Dennett S (2003) The impact of reducing dose frequency on health outcomes. Clin Ther 25:2307–2335
Roter DL (1989) Which facets of communication have strong effect on outcome – a meta-analysis. In: Stewart MA, Roter DL (eds) Communication with medical patients. Sage Publ, Newbury Park
Schroeder K, Fahey T, Ebrahim S (2004) How can we improve adherence to blood-pressure lowering medication in ambulatory care? Arch Intern Med 164:722–732
Senior V, Marteau TM, Weinman J (2004) Genetic risk assessment for FH Trial (Grafts) Study Group. Self-reported adherence to cholesterol-lowering medication in patients with familial hypercolesterolaemia: the role of illness perceptions. Cardiovasc Drug Ther 18:475–481
Sewitch MJ, Dobkin PL, Bernatsky S, Baron M, Starr M, Cohen M, Fitzcharles MA (2004) Medication non-adherence in women with fibromyalgia. Rheumatology (Oxford) 43:648–654
Sidel J, Ryan K, Nemis-White J (1998) Shaping the healthcare environment through evidence-based medicine: A case study of the ICONS project. Hosp Quart 2:29–33
Statistical Analysis System (1995) Statistical Analysis System. SAS Institute, Cary, N.C.
Stewart MA (1984) What is a successful doctor-patient interview? A study of interactions and outcomes. Soc Sci Med 19:167–175
Tibblin G, Tibblin B, Peciva S, Kullman S, Svärdsudd K (1990) The Göteborg Quality of Life Instrument-an assessement of well-being and symptoms among men born in 1913 and 1923, methods and validity. Scand J Prim Health Care Suppl 1:33–38
Wahl C, Gregoire JP, Teo K, Beaulieu M, Labelle S, Leduc B, Cochrane B, Lapointe L, Montague T (2005) Concordance, compliance and adherence in healthcare: closing gaps and improving outcomes. Healthcare Q 8:65–70
Van den Brandt PA, Petri H, Dorant E, Goldbohm RA, Van de Crommert S (1991) Comparison of questionnaire information and pharmacy data on drug use. Pharm Weekblad 13:91–96
Vlasnik J, Aliotta S, DeLor B (2005) Medication adherence: Factors influencing compliance with prescribed medication plans. Case Manager 16:47–51
Acknowledgements
This study was supported by grants from The Swedish Foundation for Health Care Sciences and Allergy Research, from the Epidemiology Department of AstraZeneca R&D Mölndal and from Uppsala University.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bardel, A., Wallander, MA. & Svärdsudd, K. Factors associated with adherence to drug therapy: a population-based study. Eur J Clin Pharmacol 63, 307–314 (2007). https://doi.org/10.1007/s00228-006-0246-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-006-0246-4